Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Omega 3s: Severe arrhythmia-related events - Nutraceuticals World
Research

Omega 3s: Severe arrhythmia-related events

Nutraceutical: Omega 3s

Indication: Severe arrhythmia-related events

Source: Diabetes Care, December 2011; 34:2515-2520

Research: Subjects in the study, a secondary analysis of the Alpha Omega Trial, consumed margarine supplemented with daily-recommended doses of omega 3 fatty acids (either 400 mg/day EPA-DHA, 2 grams/day ALA, a combination of all three, or placebo) over a 40-month period. The study included 1014 people with diabetes, ages 60-80, who had previously experienced a heart attack.

Results: The study found that all groups receiving additional amounts of these fatty acids experienced a lower incidence of events indicative of severe arrhythmias (sudden death, cardiac arrest and placement of cardioverter defibrillators), but only the group receiving a combined supplementation of all three fatty acids experienced a significantly (84%) lower incidence than those who received placebo. There was no significant reduction in fatal heart attacks among any of the groups. However, those who received all three fatty acids saw a significantly (72%) lower incidence, compared to those who took placebo, in the combined endpoint of fatal heart attacks and indicators of severe arrhythmias.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters